Wykłady 2018


30.10.2018

Prof. Marcel Hibert (Laboratoire d’Innovation Thérapeutique, Faculty of Pharmacy, University of Strasbourg, Francja)

Tytuł wykładu: "In the shadow of Eros: medicinal chemistry of love and autism?"



18.10.2018
Prof. Martin Schwab (Institute of Regenerative Medicine (IREM), University of Zurich and Dept. of Health Sciences and Technology, ETH Zurich)

Tytuł wykładu: Neurobiological mechanisms of functional recovery after spinal cord injury or stroke; the long way from the lab bench to the clinic with a neurite growth enhancing therapy.



2.10.2018

Prof. Sabatino Maione (Department of Experimental Medicine, Division of Pharmacology, University of Campania "L. Vanvitelli", Neapol, Włochy)

Tytuł wykładu: N-acylethanolamines modulate pain transmission and the associated maladaptive neuroplasticity


12.06.2018

Dr  Eliyahu Dremencov (Institute of Molecular Physiology and Genetics, Centre for Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratysława, Słowacja)
Tytuł wykładu: “The effect of prenatal immune challenge in rats on the maternal-care behavior and on monoamine neurotransmission in offsprings”.



4.06.2018
Prof. Yousef Tizabi (Department of Pharmacology, Howard University College of Medicine, Washington, USA)
Tytuł wykładu: "In Search of Novel Antidepressants and/or Neuroprotectants".




7.05.2018
Prof. Robert J. Lefkowitz, MD (Duke University Medical Center, USA)
Tytuł wykładu: "Seven transmembrane receptors".


09.04.2018
Prof. dr hab. Daniel Svozil (University of Chemical Technology, Department of Informatics and Chemistry, Praga)
Tytuł wykładu: „Molecular morphing - artificial non-intelligent way for de novo molecular design”.



 

01.03.2018
Dr Dasiel O. Borroto Escuela (Department of Neuroscience, Karolinska Institutet, Sztokholm)  
Tytuł wykładu:  “Allosteric receptor-receptor interactions in homo-and heteroreceptor complexes give a new dimension to the understanding of substance use disorder”.